The Delhi High Court recently heard a case of a three-year-old child diagnosed with LRBA deficiency. Consequently, this case highlights the strict criteria for rare disease financial assistance under the NPRD 2021. Specifically, the Union Government opposes the child's plea because her condition does not appear on the notified list. Therefore, she currently lacks access to lifesaving financial support.

Understanding LRBA Deficiency

LRBA deficiency represents a rare genetic immune disorder that severely impairs immune system regulation. As a result, patients experience recurrent life-threatening infections and severe multi-system autoimmune complications. Specialists at AIIMS Delhi and CMC Vellore confirmed this diagnosis using whole-genome sequencing. Ultimately, clinical experts concluded that an allogeneic hematopoietic stem cell transplant is the only curative option. However, this complex procedure costs approximately Rs 40 lakh, placing an immense burden on the family.

Challenges in Rare Disease Financial Assistance

For instance, the NPRD 2021 framework provides substantial financial support up to Rs 50 lakh per patient. However, the policy limits this assistance to only 63 notified rare diseases. Furthermore, since the policy omits LRBA deficiency from this list, the government rejected the petitioner's funding request. Additionally, the Centre maintained that expanding the disease list is strictly a policy decision. Thus, judicial intervention cannot mandate changes to the current executive policy framework. In addition, the government noted that public health remains primarily under State Government jurisdiction.

Frequently Asked Questions

Q1: What is LRBA deficiency?

LRBA deficiency is a rare and severe genetic immune disorder caused by mutations in the LRBA gene. It severely impairs immune regulation, leading to frequent infections, anemia, and autoimmune complications across multiple organs.

Q2: Why did the government deny funding under the NPRD 2021?

The Union Government denied assistance because LRBA deficiency is not currently among the 63 notified rare diseases covered under the National Policy for Rare Diseases (NPRD), 2021 framework.

Q3: What is the maximum financial aid available under NPRD 2021?

The National Policy for Rare Diseases provides financial support of up to Rs 50 lakh per eligible patient, with diagnostic and treatment requests routed through 15 designated Centres of Excellence.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Delhi HC told rare disease patient not eligible for aid under NPRD 2021, Centreopposes plea - ETHealthworld


2. Successful Haematopoietic Stem Cell Transplantation for LRBA Deficiency with Fludarabine, Treosulfan, and Thiotepa-Based Conditioning - Journal of Clinical Immunology


3. 3-year-old girl, rare disease, and a 'constitutional right': Delhi HC seeks Centre's response on funding plea - Hindustan Times